The purpose of this program is to provide seed funding for highly innovative research with significant potential to accelerate the mission of the Lustgarten Foundation. Proposals should address key outstanding questions and have the potential to lead to a change in the current paradigm or conventional wisdom. Proposals that involve collaborations across groups or that bring new expertise and/or technology into the pancreatic cancer research field will be preferred.
Preliminary data is not required in the proposal, but the underlying premise or hypothesis must be plausible and testable, and the proposal must be focused on a well-defined goal that is achievable within the timeframe of the award.
Research topics are not restricted and may address topics relevant to the priorities and goals of the Lustgarten Foundation (Early Detection and Interception, Therapeutic Development, Personalized Medicine). Preference will be given to proposals addressing understudied and/or poorly understood aspects of pancreatic cancer biology.
The Innovation and Collaboration Program is not intended to support proposals aiming to incrementally advance existing hypotheses, ongoing areas of research, or proposals with the sole goal of generating novel reagents or resources.